跳至主要内容
临床试验/CTRI/2019/03/018030
CTRI/2019/03/018030已完成3 期

Pharmaceutical Study of Harishankara Rasa and Its Efficacy in the Management of Madhumeha (Type 2 Diabetes)

IPGT and RA0 个研究点目标入组 56 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients having chief & associated complains of Madhumeha(Prabhuta-Avilamutrata, pipashadhikya, kshudhadhikya etc)
  • Patients having Fasting blood sugar level >= 126 mg/dl and or PPBS level >= 200 mg/dl
  • Known patient of Type2 Diabetes and also the preliminarily diagnosed patients on the basis of signs and symptoms of the disease are confirmed by FBS and PPBS.

排除标准

  • Age more than 60 and below 30 years
  • Prameha pidaka (Diabetic nonhealing wound), Systemic infection, active infection other than superficial mild skin infestation
  • Secondary Diabetes mellitus.
  • Patients of any other severe illness.
  • Diabetes mellitus Type 1
  • Malignant and accelerated hypertensive.
  • Other chronic debilitating diseases.
  • Pregnant woman and expecting conception (within six month)
  • Lactating mothers.
  • Patients with fatal diabetic complication like end stage renal disease
  • Patient with diabetic ketoacidosis

研究者

发起方
IPGT and RA

相似试验